Profile data is unavailable for this security.
About the company
NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.
- Revenue in CNY (TTM)53.59bn
- Net income in CNY577.83m
- Incorporated1994
- Employees4.90k
- LocationNanJing Pharmaceutical Co LtdBuilding 8(Nanjng Intrntnl Hlth Indl Prk,No.1 YjXiaoxingli, Yuhuatai DistrictNANJING 210012ChinaCHN
- Phone+86 2 584552601
- Fax+86 2 584552601
- Websitehttps://www.njyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai New World Co Ltd | 1.13bn | 31.66m | 3.90bn | 1.20k | 123.24 | 0.9336 | -- | 3.44 | 0.0489 | 0.0489 | 1.75 | 6.46 | 0.1989 | 4.04 | 9.34 | 942,475.30 | 0.5521 | 0.5242 | 0.7459 | 0.7249 | 37.63 | 33.70 | 2.78 | 2.71 | 1.44 | -- | 0.1252 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
NanJing Pharmaceutical Co Ltd | 53.59bn | 577.83m | 6.21bn | 4.90k | 10.78 | 0.9519 | -- | 0.1159 | 0.4397 | 0.4397 | 40.75 | 4.98 | 1.78 | 8.70 | 4.11 | 10,929,970.00 | 2.37 | 2.32 | 8.06 | 8.94 | 5.98 | 6.41 | 1.33 | 1.30 | 1.09 | 2.91 | 0.6148 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
Guangxi LiuYao Group Co Ltd | 20.45bn | 800.82m | 8.29bn | 5.16k | 10.36 | 1.27 | -- | 0.4055 | 2.21 | 2.21 | 56.44 | 17.97 | 1.02 | 7.66 | 1.96 | 3,961,076.00 | 4.36 | 5.37 | 11.45 | 12.66 | 11.26 | 11.68 | 4.27 | 4.48 | 1.26 | 6.34 | 0.5641 | 30.45 | 11.19 | 15.06 | 24.42 | 11.81 | -0.6923 | 8.57 |
Data as of Apr 18 2024. Currency figures normalised to NanJing Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
GF Fund Management Co., Ltd.as of 30 Jun 2023 | 6.45m | 0.62% |
Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 4.83m | 0.46% |
HuaAn Fund Management Co., Ltd.as of 30 Jun 2023 | 4.60m | 0.44% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 2.69m | 0.26% |
Lion Fund Management Co., Ltd.as of 30 Jun 2023 | 2.51m | 0.24% |
China Fund Management Co., Ltd.as of 30 Jun 2023 | 1.98m | 0.19% |
Gfund Management Co., Ltd.as of 30 Jun 2023 | 1.58m | 0.15% |
Orient Securities Asset Management Co. Ltd.as of 30 Jun 2023 | 959.60k | 0.09% |
China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 500.70k | 0.05% |
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2023 | 95.70k | 0.01% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.